ArticleVeterinary research communications2025
Modified aluminum (Al)-hematoxylin stain for detection of Al in sheep and cat tissues: an animal model for the study of Al-associated conditions.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Macrophage-MediatedACS applied materials & interfaces · 2026Article
- Biomimetic Apatite Nanoparticles and Microcrystalline Tyrosine as Biocompatible Vaccine Adjuvants: Performance in a Bluetongue Virus Sheep Model.ACS applied materials & interfaces · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aluminum (Al) has been an effective adjuvant in vaccines for nearly a century in animals and humans. Al can induce persistent granulomatous inflammatory responses characterized by macrophages with large granular, blue-gray cytoplasm sometimes with intracytoplasmic structures known as crystalloid bodies. These granulomas have been linked to proliferative and neoplastic conditions at injection sites in animal and humans. The detection of Al in tissue is crucial but current methods are time-intensive and require specialized training. This study highlights the efficacy of the modified Al-hematoxylin (MAH) technique in animals. Tissues from Al-induced lesions in sheep and cats were examined, along with non-aluminum granulomas as controls and MAH results were confirmed with lumogallion staining. In sheep, MAH positively stained granuloma macrophages, crystalloid bodies, necrotic regions and nearby connective tissue macrophages, while lymphoid aggregates present in granulomas were consistently negative. Macrophages loaded with Al and crystalloid bodies in lymph nodes were also MAH-positive, as were macrophages in contaminated injection sites following application of commercial Al-based vaccines. In cats with Feline Injection Site Sarcoma (FISS), MAH detected macrophage clusters around the tumor periphery and within the sarcoma. This cost-effective, rapid, and specific technique provides valuable insights for diagnosing Al-related conditions and could serve as an animal model for other species, including humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.